Details of the transaction were not announced.

By: |

The division will become its own company, though details on the new entity were not disclosed.

Latest News

Americas

The Biopesticide Market Is Thriving

Sector on track to double market share in the next five years.

Americas

Monsanto Calls for Retraction of WHO’s Glyphosate Assessment

Classification as probable carcinogen goes against scientific consensus, industry experts and scientists say.

Americas

Adama Posts Higher Profit for Year, Weighs IPO Options

"Various possibilities" are being examined regarding executing the business combination between the company and the China business.

Americas

Monsanto’s Fraley ‘Outraged’ by WHO Glyphosate Assessment

"Result was reached by selective ‘cherry picking’ of data and is a clear example of agenda-driven bias.” --Fraley

Americas

World Health Organization Report Contradicts Scientific Findings on Glyphosate

"Review does not meet the standards used by respected agencies around the world," says Dr. Phillip Miller, Monsanto global regulatory lead.